We are live on
!
Find out more
RMSCM
R.M. Sincerbeaux Capital Management Portfolio holdings
AUM
$188M
1-Year Est. Return
12.59%
This Fund
S&P 500
This Quarter
Est. Return
+6.86%
1 Year Est. Return
+12.59%
3 Year Est. Return
+76.42%
5 Year Est. Return
+87.03%
10 Year Est. Return
+380.68%
AUM
$106M
AUM Growth
+$3.05M
(+3%)
Cap. Flow
-$2.11M
Cap. Flow
% of AUM
-2%
Top 10 Holdings %
Top 10 Hldgs %
49.68%
Holding
55
New
1
Increased
3
Reduced
10
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$2.17M |
| 2 |
Crown Castle
CCI
|
+$123K |
| 3 |
AbbVie
ABBV
|
+$54.9K |
| 4 |
Williams Companies
WMB
|
+$24.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinder Morgan
KMI
|
+$1.64M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$1.01M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$900K |
| 4 |
Visa
V
|
+$338K |
| 5 |
Phillips 66
PSX
|
+$209K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.72% |
| 2 | Financials | 22.05% |
| 3 | Energy | 15.8% |
| 4 | Healthcare | 9.91% |
| 5 | Industrials | 8.93% |
Similar funds
AAA
BI
CCM
SCGM
DC
IWAO
CBT
PWM
R.M. Sincerbeaux Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, R.M. Sincerbeaux Capital Management held 55 positions worth $106M, up 3% from $103M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
R.M. Sincerbeaux Capital Management's Q4 2016 filing shows 1 new, 3 increased, 10 reduced and 2 closed positions. Its largest new stake was Viatris: 58,300 shares worth $2.22M. The largest sale was Kinder Morgan, an estimated $1.64M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Energy.
- R.M. Sincerbeaux Capital Management's largest Q4 2016 buy was Viatris: 58,300 shares worth $2.22M.
- R.M. Sincerbeaux Capital Management added most to Crown Castle in Q4 2016, an estimated $123K increase.
- R.M. Sincerbeaux Capital Management's biggest Q4 2016 reduction was Kinder Morgan, cutting an estimated $1.64M.
- R.M. Sincerbeaux Capital Management fully exited Teva Pharmaceuticals in Q4 2016, selling an estimated $900K.
- R.M. Sincerbeaux Capital Management's ten largest holdings make up 50% of its $106M portfolio in Q4 2016.
- R.M. Sincerbeaux Capital Management opened 1 new position and closed 2 in Q4 2016.
- R.M. Sincerbeaux Capital Management's portfolio value rose 3% quarter-over-quarter to $106M.
Based on R.M. Sincerbeaux Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.